Acceptability Dermacyd Wipes - Lactoserum - Hygiene
Phase 3
Completed
- Conditions
- Hygiene
- Registration Number
- NCT00397527
- Lead Sponsor
- Sanofi
- Brief Summary
The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Wipes
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
- Integral skin in the tested region
Exclusion Criteria
- Pregnancy or breastfeeding women;
- Use of antiinflammatory or immunosuppression drugs;
- Topical medication use at the region to be treated;
- Cutaneous disease or active gynaecological disease which may interfer in study results;
- Personal history of allergic disease at the area to be treated;
- Allergic or atopic history.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Adverse events and their association with the treatment.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sanofi-Aventis
🇧🇷São Paulo, Brazil
Sanofi-Aventis🇧🇷São Paulo, Brazil